Add-on Therapy With the α-Blockers Tamsulosin and Naftopidil Improves Voiding Function by Enhancing Neuronal Activity in Prostatic Hyperplasia Rats
Purpose Benign prostatic hyperplasia (BPH) impacts quality of life in men by causing lower urinary tract symptoms. α1-Adrenoceptor (α1-AR) blockers improve lower urinary tract symptoms. We investigated the efficacy of add-on therapy with α1-AR blockers on BPH rats. Methods Rats in the drug-treated g...
Main Authors: | Il-Gyu Ko, Lakkyong Hwang, Jun-Jang Jin, Sang-Hoon Kim, Jin Hee Han, Jung Won Jeon, Sung Tae Cho |
---|---|
Format: | Article |
Language: | English |
Published: |
Korean Continence Society
2018-03-01
|
Series: | International Neurourology Journal |
Subjects: | |
Online Access: | http://www.einj.org/upload/pdf/inj-1836064-032.pdf |
Similar Items
-
Afferent Pathway-Mediated Effect of α1 Adrenergic Antagonist, Tamsulosin, on the Neurogenic Bladder After Spinal Cord Injury
by: Jin-Hee Han, et al.
Published: (2017-09-01) -
Comparative evaluation of naftopidil and tamsulosin in the treatment of patients with lower urinary tract symptoms with benign prostatic hyperplasia
by: Mahavir Singh Griwan, et al.
Published: (2014-01-01) -
A comparison of the efficacy of naftopidil and tamsulosin hydrochloride in medical treatment of benign prostatic enlargement
by: Chenthil Perumal, et al.
Published: (2015-01-01) -
Effectiveness and safety of Tadalafil-SZ (NJSC “Northern Star”) at 5 mg / day in patients with symptoms of voiding dysfunction due to prostatic hyperplasia
by: L. G. Spivak, et al.
Published: (2019-10-01) -
Nitric oxide synthase inhibitor improves de novo and long-term L-DOPA-induced dyskinesia in hemiparkinsonian rats
by: Fernando Eduardo Padovan-Neto, et al.
Published: (2011-06-01)